High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$83K
$83,235
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APLS
S
Apellis Pharmaceuticals, Inc.
Chopas James George
• Officer • VP/Chief Accounting Officer
Sell to Cover
2026-01-22
$44,924
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • VP/Chief Accounting Officer
Sell to Cover
|
2026-01-22 | $44,924 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Chopas James George
• Officer • VP/Chief Accounting Officer
Sell to Cover
2026-01-20
$14,370
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • VP/Chief Accounting Officer
Sell to Cover
|
2026-01-20 | $14,370 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Chopas James George
• Officer • VP/Chief Accounting Officer
Sell to Cover
2026-01-13
$19,369
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • VP/Chief Accounting Officer
Sell to Cover
|
2026-01-13 | $19,369 | S | Form 4 |
|
APLS
S
Apellis Pharmaceuticals, Inc.
Chopas James George
• Officer • VP/Chief Accounting Officer
Sell to Cover
2025-09-15
$4,572
|
||||||
| APLS |
Apellis Pharmaceuticals, Inc.
|
Officer • VP/Chief Accounting Officer
Sell to Cover
|
2025-09-15 | $4,572 | S | Form 4 |